What is DSIP?
Delta Sleep-Inducing Peptide. Researched for sleep and stress.
DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide originally isolated from rabbit brains. Research explored sleep promotion and stress reduction. Evidence is mixed and limited. Not FDA approved.
What the evidence says
The overall evidence grade for DSIP is C (limited — early or preliminary data, mostly mechanistic or animal). Mixed research results. Limited clinical data.
Specific findings with supporting evidence:
- May affect sleep patterns. Evidence grade C.
Best-supported outcomes:
- Research interest only.
Where marketing outpaces evidence:
- The claim that "Consistently improves sleep" is not supported by the evidence (grade C).
- The claim that "FDA approved" is not supported by the evidence (grade A).
- Marketing often overstates: Sleep cure.
- Marketing often overstates: Stress eliminator.
Dose and timing
Take it in the evening. Research compound only.
Who it's for, and who should skip it
Most relevant for:
- Research interest only.
Not appropriate for:
- Those seeking proven sleep therapy.
Safety and cautions
Caution: Mixed evidence. Research results have been inconsistent. Important: Not FDA approved. Research compound.
Common mistakes
- Expecting reliable sleep improvement.
- Using instead of proven sleep interventions.
Myths vs reality
A common misconception: DSIP reliably induces delta sleep. In reality, research results have been inconsistent.
Questions people ask
Does DSIP really help sleep? Evidence is mixed and limited.
Editorial note
This guide summarizes the published evidence on DSIP. It is educational content, not medical advice. Confirm with your clinician if you take prescription medications or manage a chronic condition.